Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient
Yıl: 2020 Cilt: 28 Sayı: 3 Sayfa Aralığı: 192 - 195 Metin Dili: İngilizce DOI: 10.5336/caserep.2019-71948 İndeks Tarihi: 09-05-2021
Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient
Öz: Basal ganglia, which are one of the most active and permeable regions of the brain, can be reversibly or irreversibly damaged due to metabolic diseases, carbon monoxide intoxication, hypoxia, infectious and vasculitic causes. This may lead to various manifestations, especially movement disorders, but also epilepsy, encephalopathy and gait abnormalities. We present a 64-year-old female patient who had involuntary movements of the limbs. Her diffusion brain magnetic resonance imaging (MRI) showed bilateral basal ganglia hyperintense le-sions in T2 weighted flair sequences. The involvement of the basal ganglia is explained by lactic acidosis, caused by metformin usage despite chronic renal failure. In this study, we present a case of generalized choreatethosis and involvement of basal ganglia due to lactic acidosis in end stage renal failure.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- 1. Wang HC, Brown P, Lees AJ. Acute movement disorders with bilateral basal ganglia lesions in uremia. Mov Disord. 1998;13(6): 952-7. [Crossref] [PubMed]
- 2. Nzwalo H, Sá F, Capela C, Ferreira F, Basílio C. Reversible acute parkinsonism and bilateral Basal Ganglia lesions in a diabetic uremic patient. Case Rep Neurol. 2012;4(3):156-8. [Crossref] [PubMed] [PMC]
- 3. Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg. 2004;107(1):1-16. [Crossref] [PubMed]
- 4. Li JYZ, Yong TY, Sebben R, Khoo E, Disney APS. Bilateral basal ganglia lesions in patients with end-stage diabetic nephropathy (Brief Communication). Nephrology (Carlton). 2008:13(1);68-72. [Crossref] [PubMed]
- 5. Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, et al. Review on uremic toxins: Classification, concentration, and inter individual variability. Kidney Int. 2003;63(5):1934-43. [Crossref] [PubMed]
- 6. Yoon CH, Seok JI, Lee DK, An GS. Bilateral basal ganglia and unilateral cortical involvement in a diabetic uremic patient. Clin Neurol Neurosurg. 2009;111(5):447-79. [Crossref] [PubMed]
- 7. Spadoni F, Stefani A, Morello M, Lavaroni F, Giacomini P, Sancesario G. Selective vulnerability of pallidal neurons in the early phases of manganese intoxication. Exp Brain Res. 2000;135(4):544-51. [Crossref] [PubMed]
- 8. Chen PY, Wang HC. Unstable blood sugar levels as triggers for the syndrome of acute bilateral basal ganglia lesions in diabetic uremia: two taiwanese patients with unusual neuroimaging findings. eNeurologicalSci. 2019;14:85-8. [Crossref] [PubMed] [PMC]
- 9. Lee PH, Shin DH, Kim JW, Song YS, Kim HS. Parkinsonism with basal ganglia lesions in a patient with uremia: evidence of vasogenic edema. Parkinsonism Relat Disord. 2006;12(2):93-6. [Crossref] [PubMed]
- 10. Anderson JC, Costantino MM, Stratford T. Basal ganglia: anatomy, pathology, and imaging characteristics. Curr Probl Diagn Radiol. 2004;33(1):28-41. [Crossref] [PubMed]
- 11. Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care. 1999;22(6):925-7. [Crossref] [PubMed]
- 12. Guldiken B, Ustundag S, Yılmaz A, Cakır H. Bilateral basal ganglia lesions associated with lactic acidosis in an end-stage renal failure patient. Turk J Neurol. 2009;15(1):44-9.
- 13. Jung EY, Cho HS, Seo JW, Kim DW, Kim HJ, Chang SH, et al. Metformin-induced encephalopathy without lactic acidosis in a patient with contraindication for metformin. Hemodial Int. 2009;13(2):172-5. [Crossref] [PubMed]
- 14. Runge S, Mayerle J, Warnke C, Robinson D, Roser M, Felix SB, et a. Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation? Diabetes Obes Metab. 2008;10(1):91-3. [PubMed]
- 15. Vander T, Hallevy H, Ifergane G, Herishanu YO. Metformin-induced encephalopathy without lactic acidosis. Diabet Med. 2004; 21(2):194-5. [Crossref] [PubMed]
- 16. Bruijstens LA, van Luin M, Buscher-Jungerhans PM, Bosch FH. Reality of severe metformin- induced lactic acidosis in the absence of chronic renal impairment. Neth J Med. 2008;66(5):185-90. [PubMed]
- 17. Guelho D, Paiva I, Carrilho F. [Relation between metformin treatment and the development of hyperlactacidemia at the emergency room]. Acta Med Port. 2014;27(2),196-203. [PubMed]
- 18. Lalau JD, Andrejak M, Morinière PH, Coevoet B, Debussche X, Westeel PF, et al. Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int J Clin Pharmacol Ther Toxicol. 1989;27(6):285-8. [PubMed]
- 19. Goodman JW, Goldfarb DS. The role of continuous renal replacement therapy in the treatment of poisoning. Semin Dial. 2006;19(5):402-7. [Crossref] [PubMed]
| APA | Çakar M, Özkan H (2020). Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient. , 192 - 195. 10.5336/caserep.2019-71948 |
| Chicago | Çakar Merve Melodi,Özkan Hülya Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient. (2020): 192 - 195. 10.5336/caserep.2019-71948 |
| MLA | Çakar Merve Melodi,Özkan Hülya Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient. , 2020, ss.192 - 195. 10.5336/caserep.2019-71948 |
| AMA | Çakar M,Özkan H Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient. . 2020; 192 - 195. 10.5336/caserep.2019-71948 |
| Vancouver | Çakar M,Özkan H Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient. . 2020; 192 - 195. 10.5336/caserep.2019-71948 |
| IEEE | Çakar M,Özkan H "Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient." , ss.192 - 195, 2020. 10.5336/caserep.2019-71948 |
| ISNAD | Çakar, Merve Melodi - Özkan, Hülya. "Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient". (2020), 192-195. https://doi.org/10.5336/caserep.2019-71948 |
| APA | Çakar M, Özkan H (2020). Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient. Türkiye Klinikleri Journal of Case Reports, 28(3), 192 - 195. 10.5336/caserep.2019-71948 |
| Chicago | Çakar Merve Melodi,Özkan Hülya Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient. Türkiye Klinikleri Journal of Case Reports 28, no.3 (2020): 192 - 195. 10.5336/caserep.2019-71948 |
| MLA | Çakar Merve Melodi,Özkan Hülya Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient. Türkiye Klinikleri Journal of Case Reports, vol.28, no.3, 2020, ss.192 - 195. 10.5336/caserep.2019-71948 |
| AMA | Çakar M,Özkan H Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient. Türkiye Klinikleri Journal of Case Reports. 2020; 28(3): 192 - 195. 10.5336/caserep.2019-71948 |
| Vancouver | Çakar M,Özkan H Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient. Türkiye Klinikleri Journal of Case Reports. 2020; 28(3): 192 - 195. 10.5336/caserep.2019-71948 |
| IEEE | Çakar M,Özkan H "Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient." Türkiye Klinikleri Journal of Case Reports, 28, ss.192 - 195, 2020. 10.5336/caserep.2019-71948 |
| ISNAD | Çakar, Merve Melodi - Özkan, Hülya. "Movement Disorder Due to Involvement of Bilateral Basal Ganglia in Diabetic Uremic Patient". Türkiye Klinikleri Journal of Case Reports 28/3 (2020), 192-195. https://doi.org/10.5336/caserep.2019-71948 |
